伽玛刀放射外科治疗微血管减压术后复发性三叉神经痛
该回顾性研究纳入2065例三叉神经痛患者中59例微血管减压术后接受挽救性伽玛刀治疗者,首次随访83.1%疼痛缓解,1、2、5年无复发率分别为77%、45.9%、30.7%,面部麻木降低复发风险,初始疼痛反应差增加复发风险。
要点
- 微血管减压术后复发三叉神经痛接受挽救性伽玛刀,83.1%首次随访疼痛缓解。
- 中位复发时间1.75年,1、2、5年无复发率分别为77%、45.9%、30.7%。
- 面部麻木降低复发风险(HR 0.15),初始疼痛反应差增加复发风险(HR 3.64)。
核心结论
- 挽救性伽玛刀是微血管减压术后复发性三叉神经痛的有效无创选择,缓解率与初次伽玛刀或微血管减压相当,并发症谱优于挽救性微血管减压。
- 术后面部麻木和初始疼痛反应较好的患者可能获得更持久的疼痛缓解。
研究设计与样本
- 回顾性研究,纳入Wake Forest大学医学院接受伽玛刀治疗Burchiel 1型或2型三叉神经痛的全部患者。
- 2065例三叉神经痛患者中59例在微血管减压术后接受伽玛刀治疗。
- 疼痛采用Barrow神经学研究所疼痛强度评分,初始缓解为I-III级,复发为IV或V级。
- 采用Kaplan-Meier估计疼痛缓解持久性,Cox回归模型分析复发预测因素,统计学显著性设定为p<0.05。
主要发现
- 59例中49例(83.1%)在伽玛刀后首次随访时疼痛评分为I-III级。
- 中位复发时间1.75年,1年、2年、5年无复发率分别为77%、45.9%、30.7%。
- 微血管减压前射频消融显著降低挽救性伽玛刀初始缓解的可能性(Fisher精确检验,p=0.02)。
- 控制基线和临床特征后,面部麻木显著降低疼痛复发风险(Cox回归,HR 0.15,95%CI 0.03-0.73;p=0.01)。
- 初始疼痛反应较差显著增加疼痛复发风险(Cox回归,HR 3.64,95%CI 1.02-12.95;p=0.04)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Gamma Knife radiosurgery (GKRS) is a treatment option for refractory trigeminal neuralgia (TN). However, there is a paucity of data regarding the effectiveness of GKRS for relapsing TN following microvascular decompression (MVD). The aim of this study was to characterize the response rate, complications, pain relief durability, and predictors of pain relapse for salvage GKRS following MVD for TN. METHODS: A retrospective study of all patients who received GKRS for Burchiel type 1 TN (TN1) or type 2 TN (TN2) pain at Wake Forest University School of Medicine was conducted. Pain was measured using the Barrow Neurological Institute (BNI) pain intensity score. After an initial pain response of BNI scores I-III, a BNI score of IV or V constituted relapse. Durability of pain relief was characterized using the Kaplan-Meier estimator. Predictors of relapse were investigated using Cox regression models. Statistical significance was set at p < 0.05. RESULTS: Of 2065 patients with TN1 or TN2, 59 had GKRS post-MVD. Forty-nine (83.1%) of these patients experienced a BNI pain score of I-III at the first follow-up post-GKRS. The median time to relapse was 1.75 years; freedom rates from relapse were 77%, 45.9%, and 30.7% at 1, 2, and 5 years, respectively. Radiofrequency ablation prior to MVD significantly decreased the likelihood of an initial response to salvage GKRS (Fisher's exact test, p = 0.02). After controlling for baseline and clinical characteristics, facial numbness significantly decreased the likelihood of pain relapse (Cox regression, HR 0.15, 95% CI 0.03-0.73; p = 0.01). Conversely, a worse initial pain response significantly increased the likelihood of pain relapse (Cox regression, HR 3.64, 95% CI 1.02-12.95; p = 0.04). Pain relapse within 24 months of the original MVD did not predict durability of pain relief following salvage GKRS (Cox regression, HR 0.94, 95% CI 0.40-2.22; p = 0.89). The overall toxicity rate of salvage GKRS was 35.6%. CONCLUSIONS: Salvage GKRS presents an effective, noninvasive option for recurring TN after MVD, with a comparable response rate to primary GKRS or MVD, and a favorable complications profile relative to salvage MVD. Patients with postoperative facial numbness and a better initial pain response may experience more durable pain relief following salvage GKRS.
引用
- Horn AC, Kolahi Sohrabi A, Chan MD, et al. Gamma Knife radiosurgery for relapsing trigeminal neuralgia following microvascular decompression. J Neurosurg. 2024. PMID: 39612504. doi:10.3171/2024.7.JNS232274
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。